Anthera

Showing 1 posts of 1 posts found.

shutterstock_159488225

Anthera pulls the plug on Sollpura after Phase 3 failure, shares plummet 84%

March 13, 2018
Manufacturing and Production, Research and Development Anthera, Eli Lilly, Sollpura, pharma, trial failure

Anthera Pharmaceuticals has announced that it is to terminate development of its investigational pancreatic enzyme replacement therapy (PERT) Sollpura after …

Latest content